FreshBlood featured on PharmaExec Podcast

Written By Spelling Communications

Robert Finkel, the CEO of The FreshBlood Group talks with PharmExec editors about the positives and negatives of pharma’s marketing needs, the details and evolution around founding The FreshBlood Group, and how emerging pharma and biotech companies can budget in successful marketing.

Spelling Communications
Previous

Artifex Featured in Animation Magazine for "Are You Afraid of the Dark"
Next

Another great night at an Evening to Foster Dreams